Breast Cancer Research and Treatment

, Volume 126, Issue 3, pp 729–738 | Cite as

Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association

  • Bilal Majed
  • Adrien Dozol
  • Laureen Ribassin-Majed
  • Kamel Senouci
  • Bernard Asselain


Breast cancer (BC) survivors are at increased risk of second cancers. Obesity is commonly recognized as a risk factor of BC in postmenopausal period and a prognosis factor in BC regardless of menopausal status. Our aim was to study whether overweight BC survivors were at increased risk of contralateral BC (CBC). Our population was a large cohort of women followed since a first BC without distant spread and/or synchronous CBC. Body mass index (BMI) was assessed at diagnosis time. Binary codings of BMI were used to oppose overweight and obese patients to the others. Survival analyses were used including Cox models. Assumed hypothesis of proportional hazards was explored using graphical methods, Schoenfeld residuals and time-dependant covariates. In case of non-proportional hazards, survival models were computed over time periods. Over 15,000 patients were included in our study. Incidence of CBC was 8.8 (8.3–9.3)/1000 person-years and increased during follow-up. A significant time-dependent association between overweight and CBC was observed. After 10 years of follow-up, we found a significant increased hazard of CBC among patients with a BMI above 25 kg/m2: the adjusted hazard ratio was 1.50(1.21–1.86), P = 0.001. After 10 years of follow-up, our study found a poorer prognosis among overweight BC survivors regarding CBC events. While benefits from diet habits and weight control may be expected during the long-term follow-up, they have yet to be established using randomized clinical trials.


Contralateral breast cancer Non-proportional hazards Body mass index Overweight Time-dependent covariate Breast cancer prognosis 



Breast cancer


Body mass index


Contralateral breast cancer


Hazard ratio



The authors would like to thank Roland Sage for his invaluable help.

Conflict of interest



  1. 1.
    Carmichael AR (2006) Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113(10):1160–1166PubMedCrossRefGoogle Scholar
  2. 2.
    Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20(15):3302–3316PubMedCrossRefGoogle Scholar
  3. 3.
    Chlebowski RT (2003) The American Cancer Society guide for nutrition and physical activity for cancer survivors: a call to action for clinical investigators. CA Cancer J Clin 53(5):266–267PubMedCrossRefGoogle Scholar
  4. 4.
    Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R et al (2007) Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25(17):2345–2351PubMedCrossRefGoogle Scholar
  5. 5.
    Pierce JP (2009) Diet and breast cancer prognosis: making sense of the Women’s Healthy Eating and Living and Women’s Intervention Nutrition Study trials. Curr Opin Obstet Gynecol 21(1):86–91PubMedCrossRefGoogle Scholar
  6. 6.
    Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMedGoogle Scholar
  7. 7.
    Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P (2001) Second cancers after conservative surgery and radiation for stages I–II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51(3):679–690PubMedCrossRefGoogle Scholar
  8. 8.
    Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B (1995) Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13(7):1578–1583PubMedGoogle Scholar
  9. 9.
    Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56(4):1038–1045PubMedCrossRefGoogle Scholar
  10. 10.
    Shahedi K, Emanuelsson M, Wiklund F, Gronberg H (2006) High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma. Cancer 106(6):1237–1242PubMedCrossRefGoogle Scholar
  11. 11.
    Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95(19):1467–1476PubMedGoogle Scholar
  12. 12.
    Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329–342PubMedCrossRefGoogle Scholar
  13. 13.
    Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574PubMedCrossRefGoogle Scholar
  14. 14.
    Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP (1999) Factors associated with weight gain in women after diagnosis of breast cancer Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221PubMedCrossRefGoogle Scholar
  15. 15.
    Stoll BA (1999) Perimenopausal weight gain and progression of breast cancer precursors. Cancer Detect Prev 23(1):31–36PubMedCrossRefGoogle Scholar
  16. 16.
    Rothman KJ (2008) BMI-related errors in the measurement of obesity. Int J Obes (Lond) 32(Suppl 3):S56–S59CrossRefGoogle Scholar
  17. 17.
    Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 8(9):773–783PubMedCrossRefGoogle Scholar
  18. 18.
    Dawson LA, Chow E, Goss PE (1998) Evolving perspectives in contralateral breast cancer. Eur J Cancer 34(13):2000–2009PubMedCrossRefGoogle Scholar
  19. 19.
    Prentice AM (2006) The emerging epidemic of obesity in developing countries. Int J Epidemiol 35(1):93–99PubMedCrossRefGoogle Scholar
  20. 20.
    WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894(i–xii):1–253Google Scholar
  21. 21.
    Gross AJ, Clark V (1975) Survival distributions: reliability applications in the biomedical sciences. Wiley, New YorkGoogle Scholar
  22. 22.
    Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model, 1st edn. Springer-Verlag, New YorkGoogle Scholar
  23. 23.
    Guthrie JR, Dennerstein L, Dudley EC (1999) Weight gain and the menopause: a 5-year prospective study. Climacteric 2(3):205–211PubMedCrossRefGoogle Scholar
  24. 24.
    Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM (1998) Time-dependence of hazard ratios for prognostic factors in primary breast cancer. Breast Cancer Res Treat 52(1–3):227–237PubMedCrossRefGoogle Scholar
  25. 25.
    Pichon MF, Broet P, Magdelenat H, Delarue JC, Spyratos F, Basuyau JP, Saez S, Rallet A, Courriere P, Millon R et al (1996) Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer 73(12):1545–1551PubMedCrossRefGoogle Scholar
  26. 26.
    Warwick J, Tabar L, Vitak B, Duffy SW (2004) Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer 100(7):1331–1336PubMedCrossRefGoogle Scholar
  27. 27.
    Claus EB, Stowe M, Carter D, Holford T (2003) The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 12(6):451–456PubMedCrossRefGoogle Scholar
  28. 28.
    Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7(3):382–390PubMedCrossRefGoogle Scholar
  29. 29.
    Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229–236PubMedCrossRefGoogle Scholar
  30. 30.
    Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA (2009) Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst 101(15):1058–1065PubMedCrossRefGoogle Scholar
  31. 31.
    Kollias J, Ellis IO, Elston CW, Blamey RW (1999) Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 25(6):584–589PubMedCrossRefGoogle Scholar
  32. 32.
    Majed B, Moreau T, Asselain B (2009) Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points. Breast Cancer Res Treat 115(1):193–203PubMedCrossRefGoogle Scholar
  33. 33.
    Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M (2009) The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence. Maturitas 64(2):80–85PubMedCrossRefGoogle Scholar
  34. 34.
    de la Rochefordiere A, Mouret-Fourme E, Asselain B, Scholl SM, Campana F, Broet P, Fourquet A (1996) Metachronous contralateral breast cancer as first event of relapse. Int J Radiat Oncol Biol Phys 36(3):615–621PubMedCrossRefGoogle Scholar
  35. 35.
    McTiernan A, Irwin M, Vongruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28(26):4074–4080PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Bilal Majed
    • 1
    • 2
  • Adrien Dozol
    • 3
  • Laureen Ribassin-Majed
    • 4
  • Kamel Senouci
    • 2
  • Bernard Asselain
    • 1
  1. 1.Biostatistics DepartmentCurie InstituteParisFrance
  2. 2.Arras Hospital, Epidemiology and Clinical Research Unit, SAMU/SMUR/SU/USCArrasFrance
  3. 3.Groupe Hospitalier Lariboisière-Fernand WidalAssistance Publique-Hôpitaux de Paris, Service de Santé Publique et économie de la santéParisFrance
  4. 4.Université Paris DescartesParisFrance

Personalised recommendations